Home/Filings/4/0001209191-05-011920
4//SEC Filing

SCULLION TONY 4

Accession 0001209191-05-011920

CIK 0001062216other

Filed

Feb 23, 7:00 PM ET

Accepted

Feb 24, 3:28 PM ET

Size

13.0 KB

Accession

0001209191-05-011920

Insider Transaction Report

Form 4
Period: 2005-02-22
SCULLION TONY
DirectorChief Executive Officer
Transactions
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    2005-02-228,75052,734 total
    Exercise: $0.75From: 2002-04-01Exp: 2012-04-01Common Stock (8,750 underlying)
  • Sale

    Common Stock

    2005-02-22$5.00/sh8,750$43,75090,556 total
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    2005-02-228,000300,242 total
    Exercise: $0.75From: 2001-09-04Exp: 2011-09-04Common Stock (8,000 underlying)
  • Exercise/Conversion

    Common Stock

    2005-02-22$0.75/sh+8,750$6,56399,306 total
  • Exercise/Conversion

    Common Stock

    2005-02-22$0.75/sh+8,000$6,00098,556 total
Footnotes (3)
  • [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2004.
  • [F2]Date shown is the date of grant of option. 6.25% of the shares subject to the option become exercisable following each three month period after the date of grant. Option vests in full on the fourth anniversary of the grant date.
  • [F3]Only represents the derivative securities of this class.

Issuer

MEMORY PHARMACEUTICALS CORP

CIK 0001062216

Entity typeother

Related Parties

1
  • filerCIK 0001283978

Filing Metadata

Form type
4
Filed
Feb 23, 7:00 PM ET
Accepted
Feb 24, 3:28 PM ET
Size
13.0 KB